Clinical Trial Update: S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating paclitaxel in patients with advanced ovarian, fallopian tube, or primary peritoneal cancer in remission has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Paclitaxel (Taxol) (paclitaxel)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 3 | Status: COMPLETED